The stimulation of an ER-positive breast cancer cell line (MCF7) with IGF-1 led to the identification of an IGF-1 gene signature, which was enriched for signaling pathways that are involved in mitogenesis such as ER, Ras/ERK1/2, and PI3K/Akt/mTOR. This evidence concerns the gene IGF1 and breast carcinoma.